China Vascular Stent Market Size Estimated to Cross USD 2303.5 Million By 2030, Growing at a CAGR of 10.71% | Infinium Global Research

Infinium Global Research has added a new report on China Vascular Stent Market. The report covers the analysis of regional markets of China. Moreover, the report gives insights into the factors that affect the regional performance of the market in the short run and in the long run. The China vascular stent market is a customer intelligence and competitive study of the demand, forecasts, trends, and macro indicators in China market. The dynamics including drivers, restraints, opportunities, political, socioeconomic factors, technological factors, key trends, and future prospects. The China vascular stent market was valued at USD 1,129.9 Million in 2022 and is expected to reach USD 2,303.5 Million by 2030 and grow at a CAGR of 10.71% over the forecast period.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/china/sample-request/4967

Addressing the Rising Cardiovascular Crisis: Vascular stents, integral to the treatment of cardiovascular and cerebrovascular diseases, are gaining prominence in China. It's estimated that one in 5 adults in China has a cardiovascular disease, primarily caused by factors like smoking, alcohol consumption, obesity, and hypertension. This increasing incidence of cardiovascular cases in China is significantly bolstering the demand for vascular stents.

Insurance Coverage Driving Demand: The availability of medical insurance coverage for a vast portion of the Chinese population is revolutionizing the healthcare landscape. The comprehensive health system initiated in 2009, including schemes like urban resident basic medical insurance (URBMI), urban employee basic medical insurance (UEBMI), and rural new cooperative medical scheme (RNCMS), has provided greater financial protection to millions. These schemes, alongside supplementary and private insurance, have led to an upsurge in the demand for non-invasive surgeries, supporting the continuous demand for vascular stents.

Technological Innovation and R&D: China's strong focus on technological innovation and robust research and development capabilities in the field of vascular stents is opening up immense opportunities. Emerging economies like China are becoming hubs for innovation, driving the growth of this crucial market.

Cardiovascular Disease Prevalence: Non-communicable diseases, particularly cardiovascular diseases (CVDs), are on the rise in China. CVDs are estimated to account for 87% of total adult deaths in the country, with cardiovascular disease being the leading cause of death. Smoking, heavy alcohol consumption, obesity, and hypertension have contributed to the surge in CVD cases. With the prevalence of these diseases, the vascular stent market is expected to expand in the forecast period.

Market Challenges: Despite the favorable growth prospects, the vascular stent market in China faces certain challenges. Centralized purchasing efforts have succeeded in reducing retail prices, but concerns have been raised about an overemphasis on lower prices at the expense of product quality. The oscillation between centralized and decentralized tendering makes it difficult for manufacturers to follow a consistent approach. Additionally, the fragmented nature of the market has led to intense competition in pricing, potentially hampering market growth.

Innovation as the Key: To thrive in this competitive landscape, major market players are focusing on innovation. Introducing technology-driven vascular stents that offer significant improvements over existing options is expected to generate enthusiasm among patients and cardiologists. This approach can rapidly alter marketing strategies, ensuring a competitive edge in the market.

Market Dynamics: The China vascular stent market is characterized by fragmentation. While launching comparable stents with marginal profit margins may not be a winning strategy, introducing stents with substantial technological advancements can drive industry interest and rapid adoption. Manufacturers are actively working to develop rich pipelines, positioning themselves as leaders in the market.

The China vascular stent market is on a trajectory of substantial growth, driven by a rising cardiovascular crisis, improved insurance coverage, technological innovation, and market competition. As the market continues to evolve, it offers an attractive opportunity for both established companies and newcomers to introduce groundbreaking solutions that address the cardiovascular health needs of China's population.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/china/customization/4967

Table of Content

Chapter 1. Report Overview

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

Chapter 3. Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.2.4. Challenges

3.3. PEST-Analysis

3.4. Porter's Diamond Model for China Vascular Stent Market

3.5. IGR-Growth Matrix Analysis

3.6. Competitive Landscape in China Vascular Stent Market

Chapter 4. China Vascular Stent Market by Types

4.1. Dual Therapy Stent (DTS)

4.2. Bioresorbable Vascular Scaffold (BVS)

4.3. Bio-engineered Stent

4.4. Bare Metal Stent (BMS)

4.5. Drug-eluting Stent (DES)

Chapter 5. China Vascular Stent Market by Material

5.1. Metallic Stents

5.2. Polymer

5.3. Others

Chapter 6. China Vascular Stent Market by Mode of Delivery

6.1. Self-expanding Stents

6.2. Balloon-expandable Stents

Chapter 7. China Vascular Stent Market by Product

7.1. Peripheral Stents

7.1.1. Carotid Stents

7.1.2. Renal Artery Stents

7.1.3. Femoral Stents

7.1.4. Iliac Stents

7.1.5. Other Peripheral Stents

7.2. Evar Stent Grafts

7.2.1. Abdominal Aortic Aneurysm

7.2.2. Thoracic Aortic Aneurysm

7.3. Coronary Stents

Chapter 8. China Vascular Stent Market by End User

8.1. Hospitals

8.2. Cardiac Centers

8.3. Ambulatory Surgical Centers

Chapter 9. Company Profiles

9.1 Competitive Landscape in Vascular Stent Market

9.1.1 Competitive Landscape

9.2 Company Profiles

9.2.1 Abbott Laboratories

9.2.1.1 Overview

9.2.1.2 Company Overview

9.2.1.3 Product Portfolio

9.2.2 Boston Scientific Corporation

9.2.2.1 Overview

9.2.2.2 Company Snapshot

9.2.2.3 Product Portfolio

9.2.2.4 Recent Development

9.2.3 Biosensors International Group, Ltd.

9.2.3.1 Overview

9.2.3.2 Company Overview

9.2.3.3 Product Portfolio

9.2.4 Terumo (China) Holding Co., Ltd.

9.2.4.1 Overview

9.2.4.2 Company Snapshot

9.2.4.3 Product Portfolio

9.2.4.4 Recent Development

9.2.5 Lepu Medical Technology (Beijing) Co., Ltd.

9.2.5.1 Overview

9.2.5.2 Company Snapshot

9.2.5.3 Product Portfolio

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/china/enquiry/4967

Reasons to Buy this Report:

=> Comprehensive analysis of regional markets of China vascular stent.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.